![]() |
市場調查報告書
商品編碼
2034932
全球透析導管市場:市場規模、佔有率和趨勢分析(2026-2032 年)Dialysis Catheter Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Hemodialysis and Peritoneal Dialysis Catheters |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球透析導管市場報告(至2032年)
2025年全球透析導管市場規模為3.31億美元。預計該市場將以2.6%的複合年成長率成長,到2032年將超過3.97億美元。
本報告涵蓋全球透析導管市場,包括長期血液透析導管、短期血液透析導管和腹膜透析導管。
分析包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。
市場成長的促進因素包括降低感染率的努力、透析患者數量的增加以及先進導管材料和抗菌技術的應用。然而,導管感染率的上升和動靜脈瘺(AV瘺)使用量的增加正在阻礙市場進一步成長。
市場概覽
全球透析導管市場涵蓋為需要透析的患者提供血管或腹膜通路的導管。當其他通路方式不適用時,這些裝置對於需要即時、暫時或長期透析支援的患者至關重要。
該市場包括長期血液透析導管、短期血液透析導管和腹膜透析導管。長期血液透析導管通常用於預計留置時間超過三週的情況,留置時間可從數月到數年不等。
當預計留置時間不超過三週,或需要緊急透析通路時,會使用短期血液透析導管。這些裝置在需要快速置入的急診環境中至關重要。
技術進步正在改變透析導管市場,顯著提升其安全性和性能。創新重點在於增強生物相容性、降低感染風險、提高耐用性、開發抗菌塗層、以及改良材料。這些優勢推高了平均售價,並推動了市場價值的成長。
市場促進因素
減少感染的努力
降低導管相關血流感染率是透析導管市場的主要驅動力。推動這些感染控制工作的機構包括醫療保健改善研究所 (IHI)、疾病管制與預防中心 (CDC) 以及聯邦醫療保險報銷政策的改變。
感染疾病不僅會造成可預防的成本增加,還會惡化患者的治療效果,因此醫療機構正在積極應對。減少導管相關感染疾病現在是醫院、透析中心和整個醫療系統的首要任務。
這項措施預計將增加對具有防感染功能的導管的需求。由於抗菌導管的售價較高,即使銷售成長緩慢,仍將有助於擴大市場規模。
透析患者人數增加
透析患者數量的不斷成長也是推動市場發展的重要因素。末期腎功能衰竭是一種可以透過透析治療的慢性疾病,透析導管對許多患者來說仍然必不可少。
透析患者人數的增加是由多種因素造成的,包括人口老化、高血壓盛行率上升以及肥胖和糖尿病病例的增加。
即使考慮到腎臟移植和死亡率,透析患者人數仍以每年約4%的淨成長率成長。此外,由於許多透析患者每年需要使用多根導管,導管的銷售成長速度更快。預計這一趨勢將在預測期內持續穩定成長。
尖端材料和導管設計
先進材料和導管設計的改進正在推動市場成長。為了應對導管相關感染疾病和併發症等長期存在的挑戰,製造商正在開發具有更高生物相容性、耐用性和安全性的導管。
先進技術包括抗菌塗層、肝素塗層、銀套管、抗彎曲導管桿、組織整合袖套和特殊設計的導管尖端。這些特性旨在減少感染、提高通暢性、抑制血栓症形成並增強臨床療效。
這些技術能夠實現更高的定價,從而推高平均售價 (ASP) 並擴大市場價值。採用尖端材料的導管預計將繼續成為急性透析和長期透析護理領域創新的重點。
市場限制
感染率
感染率仍然是透析導管市場的主要阻礙因素之一。與動靜脈瘺(AVF)和動靜脈移植相比,透析導管的感染率更高。
因此,透析導管通常作為最後的選擇,僅在動靜脈瘻管或移植血管不適用或尚未可用時才會使用。導管相關感染疾病可能導致預後不良、費用增加以及需要額外治療。
許多透析患者合併多種疾病,導致動靜脈瘻管和移植血管不適用,因此導管的需求仍然存在。然而,除非感染率和併發症發生率下降,否則使用透析導管的患者比例不太可能顯著增加。
動靜脈瘻管使用增加
動靜脈瘻管使用量的增加也是限制導管需求的因素。截至2022年,動靜脈瘻管使用量的增加尚未對導管市場產生顯著影響,但這種情況可能會隨著時間的推移而改變。
隨著醫生們能夠更好地預測未來的透析需求,他們可能會提前建立動靜脈瘻管。這可以減少對透析導管的需求,尤其對於那些可以直接透過動靜脈瘻管進行透析的患者。
由於動靜脈瘻管感染率較低且長期通路能力較強,因此通常優於導管。隨著規劃的完善,對導管的需求可能會減少。
與替代接取方式的競爭
根據病患的病情和治療途徑,透析導管也面臨著來自動靜脈移植和腹膜透析等其他通路方式的競爭。
如果患者適合進行動靜脈瘺或移植,由於感染和併發症的風險較低,這些選擇可能比長期使用導管更可取。
這限制了導管市場在長期照護領域的成長。雖然透析導管對於緊急通路、過渡通路以及不適合其他方法的患者仍然至關重要,但由於各方都在盡可能減少對導管的依賴,其作用也受到限制。
市場覆蓋範圍和數據範圍
目標市場及區隔
血液透析導管包括長期導管和短期導管。長期血液透析導管用於預計導管留置時間超過三週的情況,可留置數月至數年。此類導管包括傳統導管和採用先進材料製成的導管。
短期血液透析導管用於需要在三週內建立透析通路或需要緊急透析的情況。這些產品在需要快速建立透析通路的急診和急救醫療環境中至關重要。
腹膜透析導管用於輔助腹膜透析,允許透析液經腹腔注射和排放。這些裝置提供的通路與血液透析導管不同,並納入更廣泛的透析導管市場。
每個細分市場都以市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價進行分析。
這種市場細分使製造商、投資者和策略團隊能夠了解急性通路、慢性通路、感染預防、先進材料以及透析患者數量的增加如何影響全球透析導管市場。
競爭分析
貝克頓·迪金森公司(BD)已在透析導管市場,特別是長期和短期血液透析導管市場,確立了其在2025年的強大地位。儘管該公司不經營腹膜透析導管,但BD正透過其積極的行銷策略和批量折扣擴大市場佔有率。
BD公司憑藉Power-Trialysis®和DuoGlide®等產品,在動力輸注式短期血液透析導管市場佔主導地位。這些產品具有低循環率和熱敏聚氨酯導管軸,可實現高流速。該公司長期血液透析導管產品線包括Equistream®、Duet®、HemoSplit®、HemoStar®、GlidePath®、Decathlon™ DF、Reliance XK™和Pristine™。
2025 年,美敦力在整個透析導管市場中佔第二大市場。該公司憑藉其 Argyle™ 腹膜透析導管產品線在腹膜透析領域佔主導地位,該產品線包括 Tenckhoff、Curl Cath、Swan Neck、Missouri 和 Presternal 等設計。
美敦力公司也透過其Mahurkar™慢性血液透析導管(包括碳酸酯和矽膠導管)、Permcath™、Tandem-Cath™和Palindrome™等產品進軍長期血液透析市場。 2023年1月,美敦力宣布對其Mahurkar™急性雙腔高流量13.5 Fr導管進行第一級召回,原因是導管接頭可能有缺陷。
到2025年,Medcomp將佔透析導管市場第三大佔有率。該公司在長期透析導管領域擁有強大的市場地位,同時在短期透析和腹膜透析導管領域也保持著穩固的地位。其Split Stream®和Split Cath®產品為其鞏固市場地位做出了貢獻,而Trio-CT動力灌注式短期導管則推動了其成長。
技術和臨床趨勢
引入抗菌導管
隨著醫院和透析中心致力於減少導管相關血流感染,抗菌導管的重要性日益凸顯。
這些產品以較高的價格出售,有助於提升其市場價值。
先進材料導管
先進材料導管旨在提高生物相容性、耐用性和抗併發症。
這些特性有助於解決有關感染、血栓症、通暢性和導管性能等方面的問題。
高流量輸注短期血液透析導管
高流量、短期血液透析導管在急診環境中正變得越來越重要。這些裝置可以處理高流量,提供更大的臨床柔軟性。
BD 的 Power-Trialysis® 和 DuoGlide® 產品就是這股趨勢的例證。
改良長期導管設計
長期血液透析導管的設計正在不斷改進,例如透過組織穿透到袖套、抗扭轉軸、特殊尖端設計和抗菌塗層等特性。
這些改進旨在延長植入時間並減少併發症。
腹膜透析通路
腹膜透析導管仍佔相當大的市佔率。美敦力公司的Argyle™系列產品可滿足各種腹膜透析通路需求。
該部分包括接受腹膜透析而不是血液透析的患者。
AV Fistura的計劃
改善動靜脈瘻管建立方案的製定可能減少未來對導管的需求。隨著臨床醫師能夠更早預測透析需求,有些患者或許可以避免使用導管或縮短導管使用時間。
這一趨勢可能會阻礙導管市場的長期成長。
地區
本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。
iData Research 的「全球透析導管市場報告」透過設備層級分析、基於流程的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。此報告可用於評估需求、比較競爭對手、了解感染減少趨勢,並協助您制定全球透析導管市場的產業計畫。
Global Dialysis Catheter Market Report to 2032
The global dialysis catheter market was valued at $331 million in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.6%, reaching over $397 million by 2032.
This report covers the global market for dialysis catheters, including long-term hemodialysis catheters, short-term hemodialysis catheters, and peritoneal dialysis catheters.
The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.
Market growth is supported by initiatives to reduce infection, the increasing number of dialysis patients, and the adoption of advanced catheter materials and antimicrobial technologies. However, catheter infection rates and the increasing use of AV fistulae continue to limit stronger growth.
Market Overview
The global dialysis catheter market includes catheters used to provide vascular or peritoneal access for patients requiring dialysis. These devices are essential for patients who require immediate access, temporary access, or long-term dialysis support when other access methods are not suitable.
The market includes long-term hemodialysis catheters, short-term hemodialysis catheters, and peritoneal dialysis catheters. Long-term hemodialysis catheters are generally used when catheter retention is expected to exceed three weeks, with dwell times that can extend for months or years.
Short-term hemodialysis catheters are used when access is not expected to exceed three weeks or when emergency dialysis access is needed. These devices are important in acute care settings where rapid placement is required.
Technological advancements are shaping the dialysis catheter landscape by improving safety and performance. Innovation is focused on better biocompatibility, reduced infection risk, improved durability, antimicrobial coatings, and enhanced materials. These features help justify higher ASPs and support market value growth.
Market Drivers
Initiatives to Reduce Infection
Initiatives to reduce catheter-related bloodstream infections are a major driver of the dialysis catheter market. Infection reduction efforts have been supported by organizations such as the Institute for Healthcare Improvement, the Centers for Disease Control and Prevention, and Medicare reimbursement policy changes.
Medical facilities have responded positively because infections are preventable expenses that worsen patient outcomes. Reducing catheter-related infection is now a major priority for hospitals, dialysis centers, and healthcare systems.
This focus is expected to increase demand for catheters with infection-reducing properties. Antimicrobial catheters also sell at a premium, which supports market value growth even when unit growth remains moderate.
Increasing Number of Dialysis Patients
The increasing number of dialysis patients is another important market driver. End-stage renal disease is a chronic condition that can be treated through dialysis, and dialysis catheters remain necessary for many patients.
Growth in the dialysis patient population is driven by several factors, including aging populations, rising hypertension rates, and increasing rates of obesity and diabetes.
After accounting for kidney transplants and mortality, there is a net annual increase of around 4% in the number of prevalent dialysis patients. Many dialysis patients also use more than one catheter per year, resulting in even faster catheter volume growth. This trend is expected to remain steady over the forecast period.
Advanced Materials and Catheter Design
Advanced materials and catheter design improvements are supporting market growth. Given the historic challenge of catheter-related infections and complications, manufacturers are developing catheters with improved biocompatibility, durability, and safety features.
Premium technologies include antimicrobial coatings, heparin coatings, silver sleeves, kink-resistant shafts, tissue ingrowth cuffs, and specialized catheter tip designs. These features are intended to reduce infection, improve patency, limit thrombosis, and improve clinical performance.
Because these technologies can command higher prices, they support ASP growth and market value. Advanced material catheters are expected to remain an important area of innovation in both acute and long-term dialysis care.
Market Limiters
Infection Rates
Infection rates remain one of the main limiters of the dialysis catheter market. Dialysis catheters have higher infection rates than arteriovenous fistulae or AV grafts.
Because of this, dialysis catheters are often used as a last resort when fistulae or grafts are not suitable or not yet available. Catheter-related infections can lead to poor outcomes, higher costs, and additional treatment needs.
Many dialysis patients have co-existing medical conditions and are not suitable for fistulae or grafts, which preserves catheter demand. However, a meaningful increase in the percentage of patients using dialysis catheters is unlikely unless infection and complication rates decline.
Increasing Use of AV Fistulae
The increasing use of AV fistulae is another limiter. While greater use of AV fistulae has not had a drastic impact on the catheter market as of 2022, this may change over time.
As physicians become better at anticipating future dialysis needs, they may prepare fistulae in advance. This can reduce the need for dialysis catheters, especially in patients who can transition directly to fistula access.
AV fistulae are generally preferred because they have lower infection rates and better long-term access profiles than catheters. As planning improves, some catheter demand may be eliminated.
Competition from Alternative Access Methods
Dialysis catheters also face competition from alternative access methods, including AV grafts and peritoneal dialysis approaches, depending on patient condition and care pathway.
When patients are suitable for fistulae or grafts, these options may be preferred over long-term catheter use because of lower infection and complication risks.
This limits catheter growth in long-term care. Dialysis catheters remain essential for urgent access, bridge access, and patients who are not suitable for alternatives, but their role is constrained by efforts to reduce catheter dependence where possible.
Market Coverage and Data Scope
Markets Covered and Segmentation
Hemodialysis catheters include both long-term and short-term devices. Long-term hemodialysis catheters are used when catheter retention is expected to exceed three weeks and may remain in place for months or years. This segment includes conventional and advanced material catheters.
Short-term hemodialysis catheters are used when access is needed for less than three weeks or when emergency dialysis access is required. These products are important in acute and urgent care settings where rapid access is necessary.
Peritoneal dialysis catheters are used to support peritoneal dialysis, allowing dialysis fluid to be introduced and drained through the peritoneal cavity. These devices serve a different access pathway than hemodialysis catheters and are included within the broader dialysis catheter market.
Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
This segmentation helps manufacturers, investors, and strategy teams understand how acute access, chronic access, infection prevention, advanced materials, and dialysis patient growth are shaping the global dialysis catheter market.
Competitive Analysis
Becton Dickinson held a strong position in the total dialysis catheter market in 2025, particularly in long-term and short-term hemodialysis catheters. Although the company does not offer a peritoneal dialysis catheter, BD's aggressive marketing strategy and volume discounts have helped it gain share.
BD dominates the market for power-injectable short-term hemodialysis catheters with devices such as Power-Trialysis(R) and DuoGlide(R), which provide high flow rates with low recirculation and thermosensitive polyurethane shafts. Its long-term hemodialysis catheter portfolio includes Equistream(R), Duet(R), HemoSplit(R), HemoStar(R), GlidePath(R), Decathlon(TM) DF, Reliance XK(TM), and Pristine(TM).
Medtronic held the second-leading position in the total dialysis catheter market in 2025. The company performed strongly in short-term hemodialysis and dominated the peritoneal dialysis segment through its Argyle(TM) peritoneal dialysis catheter line, including Tenckhoff, Curl Cath, Swan Neck, Missouri, and Presternal designs.
Medtronic also participates in long-term hemodialysis through Mahurkar(TM) chronic Carbothane and silicone catheters, Permcath(TM), Tandem-Cath(TM), and Palindrome(TM). In January 2023, Medtronic issued a Class I recall of its Mahurkar(TM) Acute Dual Lumen High Flow 13.5 Fr catheters due to potential catheter hub defects.
Medcomp held the third-leading position in the total dialysis catheter market in 2025. The company is especially strong in long-term dialysis catheters and maintains a stable presence in short-term dialysis and peritoneal dialysis catheters. Its Split Stream(R) and Split Cath(R) products helped establish its presence, while the Trio-CT power-injectable short-term catheter supports growth.
Technology and Practice Trends
Antimicrobial Catheter Adoption
Antimicrobial catheters are becoming more important as hospitals and dialysis centers focus on reducing catheter-related bloodstream infections.
These products command premium pricing and support market value growth.
Advanced Material Catheters
Advanced material catheters are designed to improve biocompatibility, durability, and resistance to complications.
These features help address infection, thrombosis, patency, and catheter performance concerns.
Power-Injectable Hemodialysis Catheters
Power-injectable short-term hemodialysis catheters are gaining importance in acute care settings. These devices support high flow rates and can offer additional clinical flexibility.
BD's Power-Trialysis(R) and DuoGlide(R) products are examples of this trend.
Long-Term Catheter Design Improvements
Long-term hemodialysis catheter designs are improving through features such as tissue ingrowth cuffs, kink-resistant shafts, specialized tip designs, and antimicrobial coatings.
These improvements are intended to support longer dwell times and fewer complications.
Peritoneal Dialysis Access
Peritoneal dialysis catheters remain an important part of the market. Medtronic's Argyle(TM) line supports a broad range of peritoneal dialysis access needs.
This segment serves patients using peritoneal rather than hemodialysis treatment pathways.
AV Fistula Planning
Improved planning for AV fistula creation may reduce future catheter demand. As clinicians anticipate dialysis needs earlier, some patients may avoid catheter use or use catheters for shorter durations.
This trend may constrain long-term catheter growth.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Dialysis Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand infection-reduction trends, and support commercial planning in the global dialysis catheter market.